In today’s rapidly evolving healthcare landscape, navigating the reimbursement pathway for high-cost highly specialised therapies presents a formidable challenge. These treatments, including […]
Introduction Navigating the pathway to reimbursement can often feel like an uphill battle, and you’re not alone in this struggle. Market Access […]
Two environmental sustainability in healthcare conferences/webinars in one week? You must be joking. But no, it’s no joke. ISPOR Australia Chapter: Incorporating […]
Ever asked for feedback? The results can often be quite surprising. We might find ourselves pondering questions like, “Why did they focus […]
I am thrilled to have had the opportunity to speak at the ARCS Australia Conference 2024! It was an honour to share […]
On behalf of health economists, thank you to Cancer Australia for launching the Australian Comprehensive Cancer Network (ACCN)! At yesterday’s Innovation Showcase, research groups […]
Our Medicines Australia Horizon Scanning Forum presentation highlighted the journey of AI-enabled IVD from Parkinson’s prognosis to broader neurological applications. As advancements […]
The Australian Government Department of Health and Aged Care has published seven draft discussion papers as part of its HTA Policy and […]
We are excited to participate in the HTA Review as part of Medicines Australia’s Strategic Agreement with the Federal Government. This is […]
Thank you to ISPOR Australia Chapter for hosting the HTA Harmonisation Workshop yesterday in Sydney. The interactive panel discussions highlighted the lack […]
